Avid Bioservices Inc (CDMO)

[eastcoastguy]

Biopharm, Over the years I've enjoyed your posts or should I say puzzle pieces to get an idea of what PPHM might be up to. In the past you drew the connection between CSM and it's CEO and Founder- Finken. Of course we are in a major legal battle with CSM over our PH2 debacle.

For some more Cloak & Dagger stuff on a slow afternoon.

Before Finken founded CSM in 1997 he worked for BMY 1982-1993 as Manager of Clinical Investigational Drug Management. Interesting connection back to BMY

We are collaborating with MSK/BMY in combo therapy with BMY's Yervoy and Optivo.

For the past 10 years David Berman has done oncology research for BMY. From 2011-2013 he was the Global Clinical Lead for Yervoy. From 2013-2015 He was Head of the Immuno/oncology Development Team.

In June 2015 Berman left BMY and joined Medimmune the research and development arm of AstraZeneca. He is Senior VP Head of the Oncology Innovative Medicines.

BMY brings a lawsuit in June 2015 against Berman to prevent him from jumping ship. In the lawsuit it alleges that "Berman is aware of a significant amount of non-public information" pertaining to BMY's immune/oncology program development.

Our PPHM announces a collaboration with AZN.

Inquiring minds want to know:

What did Berman know about the combo therapies of Yervoy with Bavi that might help AZN with their own immune checkpoint inhibitor therapy?

There is a common thread through CSM/PPHM/BMY with Finken.

The Ph2 debacle with CSM and it's CEO (Finken)derailed a proposed deal in 2012 with Abbvie.

Who benefitted from the derailment?

Also interesting is the BMY/Berman/AZN/PPHM connection!

eastcoastguy